camptothecin has been researched along with Leishmaniasis, Visceral in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castanys, S; Castanys-Muñoz, E; Gamarro, F; Pérez-Victoria, JM | 1 |
| Alonso, C; Balaña-Fouce, R; Fuertes, M; González, M; Palacios, F; Pérez-Pertejo, Y; Reguera, RM; Rubiales, G; Tejería, A | 1 |
| Balaña-Fouce, R; Castro, MÁ; Escudero-Martínez, JM; García, PA; Jambrina, PG; Pérez-Pertejo, Y; Reguera, RM; San Feliciano, A | 1 |
| Bergeron, MG; Désormeaux, A; Marquis, JF; Olivier, M; Proulx, ME | 1 |
4 other study(ies) available for camptothecin and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Base Sequence; Biological Transport, Active; Chloroquine; DNA, Protozoan; Drug Resistance; Fluorescent Dyes; Genes, Protozoan; Humans; Leishmania infantum; Leishmaniasis, Visceral; Lipid Bilayers; Phosphorylcholine; Protozoan Proteins; Recombinant Proteins; Transformation, Genetic | 2008 |
Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase.
Topics: Animals; Antiparasitic Agents; Cells, Cultured; DNA Topoisomerases, Type I; Humans; Leishmania infantum; Leishmaniasis, Visceral; Mice; Naphthyridines; Topoisomerase I Inhibitors | 2016 |
Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB.
Topics: Animals; Anthraquinones; Antiprotozoal Agents; Camptothecin; DNA Topoisomerases; Drug Resistance; Female; Hep G2 Cells; Humans; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Naphthoquinones; Quinones; Spleen; Topoisomerase Inhibitors | 2019 |
Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin.
Topics: Animals; Antiprotozoal Agents; Camptothecin; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Stability; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Treatment Outcome | 2001 |